Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Shaw Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Battling Blood-Sucking Bugs
      • Unexpected Leads to Curb Addiction
      • Shaping Therapies for Sickle Cell Disease
      • The Mind’s Map Maker
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
I am Intramural Blog

Electronic Cigarettes Lure Former Smokers Back to Old Habits

High-Tech Nicotine Delivery Technologies Raise Risk for Relapse

By Brandon Levy

Tuesday, July 28, 2020

Using electronic cigarettes and other high-tech nicotine delivery devices makes former smokers more likely to resume smoking traditional cigarettes, according to a new study by NIH researchers.

Scholars have long debated about the use of nuclear power, gene editing, and many other technologies that can have both positive and negative effects on society. Recently, researchers have been having similar discussions about the public health effects of electronic cigarettes. Adding to this debate, a new NIH study highlights a concerning drawback of e-cigarettes by showing they increase the risk that people who have successfully quit smoking will resume using tobacco products.1

Smoking rates among American adults have fallen dramatically over the past half-century, from more than 42 percent in the 1960s to less than 14 percent today. Part of this change is due to the development of products that deliver nicotine without tobacco, such as nicotine patches and gum. The newest of these products are electronic nicotine delivery systems (ENDS), which heat up a nicotine-containing liquid until it becomes a vapor that can be inhaled. While this may be a healthier alternative to traditional cigarettes for current smokers — although the jury is still out on that question — the use of ENDS may be problematic for former smokers who have managed to go without a cigarette of any sort for months or years.

“Animals that use nicotine but have been weaned off it, if you expose them to low doses of nicotine, they’re more likely to then really seek it out and pursue what appear to be addictive patterns of nicotine use,” says Wilson Compton, M.D., the new study’s senior author and Deputy Director of the NIH’s National Institute on Drug Abuse (NIDA). “For humans, it may rekindle some of the memories and associations attached to smoking, both conscious and unconscious, that are part of why it’s so hard to quit.”

Dr. Wilson Compton, Deputy Director of the National Institute on Drug Abuse (NIDA) and the new study’s senior author.

In the new study, Dr. Compton’s team analyzed data from the Population Assessment of Tobacco and Health (PATH) Study, an ongoing study that interviews a large, diverse set of American adults and teens every year or two about their use of both ENDS and traditional tobacco products. The team’s study included data from four sets of these surveys, stretching from the start of the PATH study in 2013 up to early 2018. The NIH researchers specifically focused on nearly 2,300 adults who said during their first PATH interviews that they used to smoke but did not use any form of tobacco or ENDS at that point in time. The study also divided the PATH participants into ‘long-term’ former smokers who had abstained from those products for more than 12 months and ‘short-term’ former smokers who had quit less than 12 months before their first PATH interviews.

Over the entire time span included in the NIH team’s study, just over 95 percent of the long-term former smokers continued to avoid smoking, while roughly half of the short-term former smokers remained tobacco-free. Overall, former smokers who used ENDS at some point during the study period were nearly three times as likely to resume smoking cigarettes as those who did not use ENDS. This increased risk of relapse disproportionately affected long-term former smokers, as the use of ENDS raised relapse risk nearly three-fold for those individuals compared to a 63 percent increased risk for short-term former smokers.

“We were trying to figure out the specific risk for relapse due to using ENDS products over and above all the other reasons people might relapse,” Dr. Compton explains. “When you haven’t smoked for a long time, you don’t have a lot of reasons to relapse, so adding nicotine exposure to that increases the risk above what is really a relatively low chance of relapse. On the other hand, those who quit relatively recently have many reasons to relapse — whether that’s stress, withdrawal symptoms, they really haven’t changed their habits, or they’re around other tobacco users — and so the relative increase due to using ENDS over that base-level, more frequent rate of relapse is not as much.”

Future research in animal models will be needed to figure out the biological mechanisms that make the use of ENDS a risk factor for relapse. However, even without that knowledge, the study makes a compelling case that people who have given up smoking should be wary of trying out the high-tech equivalent.

“For those who have succeeded in quitting, there’s reason for clinicians to encourage them not to be tempted by e-cigarettes,” says Dr. Compton. “Once you’ve become abstinent, celebrate that success and don’t put it at risk by sampling e-cigarettes.”

Subscribe to our weekly newsletter to stay up-to-date on the latest breakthroughs in the NIH Intramural Research Program.

References:

[1] Association of Electronic Nicotine Delivery System Use With Cigarette Smoking Relapse Among Former Smokers in the United States. Everard CD, Silveira ML, Kimmel HL, Marshall D, Blanco C, Compton WM. JAMA Netw Open. 2020 Jun 5;3(6): e204813. doi:10.1001/jamanetworkopen.2020.4813.


Category: IRP Discoveries
Tags: Test Tube Tuesday, smoking, addiction

Related Blog Posts

  • Attempting Weight Loss Linked to Reduced Risk of Death
  • Stress-Relieving Chemical Could Combat Alcohol Use Disorder
  • Star-Shaped Brain Cells May Contribute to Marijuana Addiction
  • Neuronal Building Block Underlies Alcohol Addiction
  • Heavy Drinking Linked to Smell and Taste Alterations

This page was last updated on Tuesday, January 30, 2024

Blog menu

  • Contributing Authors
    • Anindita Ray
    • Brandon Levy
    • Devon Valera
    • Melissa Glim
  • Categories
    • IRP Discoveries
    • Profiles
    • Events
    • NIH History
    • IRP Life

Blog links

  • Subscribe to RSS feed

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search